[1] |
Go AS,Mozaffarian D,Roger VL,et al.Heart disease and stroke statistics—2013 update:a report from the American Heart Association[J].Circulation,2013,127(1):e6-e245.
|
[2] |
Nitenberg A,Chemla D,Antony I.Epicardial coronary artery constriction to cold pressor test is predictive of cardiovascular events in hypertensive patients with angiographically norma lcoronary arteries and without other major coronary risk factor[J].Atherosclerosis,2004,173(1):115-123.
|
[3] |
Spencer CG,Martin SC,Felmeden DC,et al.Relationship of homocysteine to markers of platelet and endothelial activation in “high risk” hypertensives:a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial[J].Int J Cardiol,2004,94(2-3):293-300.
|
[6] |
任阳,谢圆媛.心舒宝胶囊对气虚血瘀型老年高血压患者内皮功能的影响[J].安徽医药,2017,21(10):1891-1895.
|
[9] |
彭海东,涂晋文,田俊.灯盏花素对大鼠脑缺血再灌注后ET、TXA2和PGI2代谢的影响[J].湖北中医学院学报,2006,8(1):29-31.
|
[10] |
Du X,Chen C,Zhang M,et al.Scutellarin reduces endothelium dysfunction through the PKG-I pathway[J].Evid Based Complement Alternat Med,2015,2015:430271.
|
[4] |
Nitenberg A,Pham I,Antony I,et al.Cardiovascular outcome of patients with abnormal coronary vasomotion and normal coronary arteriography is worse in type 2 diabetes mellitus than in arterial hypertension:a 10 year follow-up study[J].Atherosclerosis,2005,183(1):113-120.
|
[5] |
Zhu K,Yang S,Ma F,et al.The novel analogue of Hirsutine as an anti-hypertension and vasodilatary agent both in vitro and in vivo[J].PLoS One,2015,10(4):e0119477.
|
[7] |
Zhang WD,Chen WS,Wang YH,et al.Studies on flavone constituents of Erigeron breviscapus (Vant.) Hand.-Mazz[J].Zhongguo Zhong Yao Za Zhi,2000,25(9):536-538.
|
[8] |
Hong H,Liu GQ.Scutellarin protects PC12 cells from oxidative stress-induced apoptosis[J].J Asian Nat Prod Res,2007,9(2):135-143.
|
[11] |
Li L,Li L,Chen C,et al.Scutellarin′s cardiovascular endothelium protective mechanism:important role of PKG-Iα[J].PLoS One,2015,10(10):e0139570.
|
[12] |
SchlegelPA,MonneyM,BrunnerHR.Isolatedperfusedmesenteric arteries of hypertensive and normotensive rats,response to noradrenaline,lysine vasopressin and angiotensin Ⅱ[J].Clin Exp Hypertens A,1985,7(11):1583-1596.
|
[13] |
叶雷,赵立琳,王健.灯盏花素注射液治疗高血压左室舒张功能不全临床观察[J].新中医,2012,44(10):15-17.
|
[14] |
赵芊,董刚.灯盏花素对高血压肾病患者血清纤维化指标及动脉弹性指标的影响[J].中国生化药物杂志,2016,36(1):151-153.
|
[15] |
李法琦,陈运贞.灯盏花素对自发性高血压大鼠心肌细胞凋亡和心室重塑的影响[J].重庆医科大学学报,2002,27(4):400-402,416.
|
[16] |
Chen X,Shi X,Zhang X,et al.Scutellarin attenuates hypertension-induced expression of brain Toll-like receptor 4/nuclear factor kappa B[J].Mediators Inflamm,2013,2013:432623.
|
[17] |
Cockcroft JR,Chowienczyk PJ,Benjamin N,et al.Preserved endothelium-dependent vasodilatation in patients with essential hypertension[J].N Engl J Med,1994,330(15):1036.
|
[18] |
王雪茜,王冬,赵伟鹏,等.三草降压汤有效组分对自发性高血压大鼠血管活性舒缩因子的影响[J].中华中医药杂志,2014,29(8):2454-2457.
|
[19] |
Shi M,Liu Y,Feng L,et al.Protective effects of Scutellarin on human cardiac microvascular endothelial cells against hypoxia-reoxygenation injury and its possible target-related proteins[J].Evid Based Complement Alternat Med,2015,2015:278014.
|
[20] |
Chen Y,Wang L,Zhou G,et al.Scutellarin attenuates endothelium-dependent vasodilation impairment induced by hypoxia reoxygenation,through regulating the PKG[J].Chinese J Natural Med,2015,13(4):1-10.
|